SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

b. The following presents segment results of operations for the six months ended June 30, 2015 (unaudited):

	Cellocator segment		MRM segment		RSA segment		Elimination			Total
Segments revenues	$	11,009	$	22,484	$	17,663	$	(869	)	$	50,287
Segments operating profit	$	1,243	$	1,717	$	592	$	159		$	3,711
Segments tangible and intangible assets	$	8,758	$	26,926	$	22,172	$	3,620		$	61,476
Depreciation and amortization	$	171	$	1,175	$	639	$	-		$	1,985
Expenditures for assets	$	79	$	906	$	369	$	-		$	1,354

c. The following presents segment results of operations for the six months ended June 30, 2014 (unaudited):

	Cellocator segment		MRM segment		RSA segment		Elimination			Total
Segments revenues	$	11,265	$	28,914	$	18,041	$	(5,331	)	$	52,889
Segments operating profit (loss)	$	1,517	$	4,778	$	768	$	(2,826	)	$	4,237
Segments tangible and intangible assets	$	9,468	$	30,278	$	20,607	$	5,434		$	71,787
Depreciation, amortization and impairment expenses	$	177	$	1,347	$	951	$	-		$	2,475
Expenditures for assets	$	104	$	1,730	$	414	$	-		$	2,248

d. The following presents segment results of operations for the three months ended June 30, 2015 (unaudited):

	Cellocator segment		MRM  segment		RSA segment		Elimination			Total
Segments revenues	$	5,545	$	11,124	$	8,921	$	(280	)	$	25,310
Segments operating profit	$	612	$	730	$	244	$	55		$	1,641
Segments tangible and intangible assets	$	8,758	$	26,926	$	22,172	$	3,620		$	61,476
Depreciation and amortization	$	85	$	584	$	310	$	-		$	979
Expenditures for assets	$	50	$	466	$	253	$	-		$	769

e. The following presents segment results of operations for the three months ended June 30, 2014 (unaudited):

	Cellocator segment		MRM  segment		RSA segment		Elimination			Total
Segments revenues	$	5,867	$	13,886	$	9,122	$	(3,001	)	$	25,874
Segments operating profit (loss)	$	933	$	900	$	263	$	(426	)	$	1,670
Segments tangible and intangible assets	$	9,468	$	30,278	$	20,607	$	5,434		$	71,787
Depreciation, amortization and impairment expenses	$	89	$	628	$	477	$	-		$	1,194
Expenditures for assets	$	72	$	739	$	283	$	-		$	1,094

f. The following presents segment results of operations for the year ended December 31, 2014:

	Cellocator segment		MRM segment		RSA segment			Elimination			Total
Segments revenues	$	24,063	$	55,911	$	36,168		$	(10,852	)	$	105,290
Segments operating profit (loss)	$	3,859	$	5,619	$	(60	)	$	(2,871	)	$	6,547
Segments tangible and intangible assets	$	8,679	$	26,878	$	22,038		$	4,405		$	62,000
Depreciation, amortization and impairment expenses	$	349	$	2,188	$	2,230		$	-		$	4,767
Expenditures for assets	$	165	$	2,586	$	1,706		$	-		$	4,457